#United States #New York #Gross Law Firm #Geron Corporation #Rytelo

Alert for Geron Corporation Investors

The Gross Law Firm has announced a significant development for shareholders of Geron Corporation (NASDAQ: GERN). Investors who acquired shares during a specific class period are encouraged to engage with the legal firm as a class action lawsuit unfolds.

Class Action Lawsuit Details

According to the notice from The Gross Law Firm, investors might be eligible for recovery related to misleading information provided by the company concerning the commercial prospects of its drug, Rytelo (imetelstat). Specifically, the firm's allegations indicate that Geron officials made overly optimistic statements about the drug's market performance while downplaying associated risks. The class period for this lawsuit spans from February 28, 2024, to February 25, 2025.

Background of the Allegations

The complaint asserts that Geron Corporation made several assertions regarding their ability to meet the needs for Rytelo and to successfully execute their marketing strategies targeting patients who are not eligible for traditional treatments. However, the reality presented itself differently as Geron disclosed in its fourth-quarter results for the fiscal year 2024 that sales for Rytelo had stagnated, attributing this lack of growth to various factors, including competitive pressures, seasonal variations, and general awareness issues among potential patients. This disclosure resulted in a sharp decline in Geron’s stock price, dropping nearly 32% in value within a day.

Important Dates for Shareholders

For those who invested in Geron shares during the specified period, the deadline to register for participation in the class action lawsuit is set for May 12, 2025. It is crucial for shareholders to register promptly to ensure they secure a position to seek recovery for their losses. Even those not interested in acting as lead plaintiffs can still participate in the recovery process.

Next Steps

After registering, shareholders will benefit from ongoing updates through portfolio monitoring software managed by the firm throughout the case's progression. This service is advantageous for investors seeking to stay informed about the evolving legal situation surrounding their investment.

Why Choose The Gross Law Firm?

The Gross Law Firm is recognized nationally for its work in class action cases, focusing on safeguarding investors against deceptive practices. They strive to hold companies accountable for misleading their shareholders and are dedicated to ensuring ethical business conduct within the financial sector. Their expertise is crucial in assisting affected investors in seeking justice and recovering losses incurred due to misleading statements or information omissions by companies.

For more information about joining the class action or to discuss potential claims, interested parties can navigate to The Gross Law Firm's dedicated website. This notice serves as an essential reminder for Geron shareholders to act timely and safeguard their investment interests.

Contact Information
The Gross Law Firm
15 West 38th Street, 12th Floor
New York, NY 10018
Email: [email protected]
Phone: (646) 453-8903

This announcement represents a pivotal moment for Geron shareholders, offering a pathway to potentially recover losses sustained due to the company's previous misrepresentations. As the deadline approaches, it's imperative that investors take actionable steps to protect their rights.